Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Mucosal Dermatology: Challenges and Advances in Diagnosis and Treatment
Description
In a presentation on mucosal dermatology, Erin discusses the challenges and advances in diagnosing and treating mucosal diseases, emphasizing the unique suffering of patients with conditions like oral lichen planus. These patients often endure significant physical discomfort without visible symptoms, leading to misconceptions about their conditions. Erin highlights the complexity of diagnosing mucosal diseases due to their hidden nature and the difficulty in obtaining accurate biopsies. Current treatments primarily involve topical corticosteroids, which are not always effective and may have side effects, prompting the investigation of systemic therapies. Advances in understanding the pathogenesis of mucosal diseases, particularly through cytokine and gene expression studies, offer hope for more targeted therapies in the future. Erin stresses the importance of recognizing the multifaceted nature of these diseases and the necessity for early diagnosis to reduce morbidity and enhance patient quality of life. She also notes that mucosal dermatology requires a nuanced treatment approach, acknowledging different disease subtypes and their responses to various therapies, including new biologic options. Overall, the talk emphasizes the need for ongoing research and clinical awareness to better address the complexities of mucosal diseases.
View moreConclusions
- Mucosal diseases, such as lichen planus, often have unique and overlapping symptoms that complicate diagnosis and treatment.
- There is significant patient morbidity associated with mucosal diseases that is often invisible, leading to misdiagnosis and delayed treatment.
- Recent advances in understanding the pathogenesis of mucosal diseases have revealed important cytokine pathways that could be targeted for therapy.
- The classification of mucosal diseases into different phenotypes helps in tailoring specific treatments that are more effective compared to a one-size-fits-all approach.
- Topical corticosteroids are often the first-line treatment, but they are not always effective, particularly in erosive lichen planus.
- New systemic medications, including biologics and JAK inhibitors, show promise for treating refractory mucosal diseases.
- Early diagnosis and treatment initiation can prevent significant patient suffering and improve quality of life.
- Comprehensive examination of all mucosal surfaces is crucial for accurate diagnosis and treatment of mucosal diseases.
- Ma Y, Front Oncol, 2021
- Rees T, Desquamative Gingivitis CE, 2019
- Gudjonsson JE, Clin Exp Immunol, 2004
- Mohd Noor, Biomechanisms, 2023
- El-Howati A, Oral Diseases, 2022
- Muller S, Mod Pathol, 2017
- Decker A, World J Gastro, 2022
- Shao Y, Exp Derm, 2023
- Klein BA, Front Oral Health, 2022
- McParland H, J Biomed Biotech, 2012
- Usatine R, AFP, 2011
- Singh AR, J Laryng Otol, 2016
- Carrozzo M, Curr Oral Hlth Rep, 2014
- Jiang L, Heliyon, 2024
- Vo, PLoS One, 2021
- Qing, eLife, 2023
- Didona, Front Med, 2022
- Abduelmula A, J Cut Med Surg, 2023
- Deng X, Front Immunol, 2023
- Turki T, Engin Appl Al, 2022